Call to action: Understanding the differences in the use of SGLT-2 inhibitors and GLP-1 receptor agonists

Cardiovascular disease remains one of the most prominent global health problems and has been demonstrated to disproportionally affect certain communities. Despite an increasing collective effort to improve health inequalities, a multitude of disparities continue to affect cardiovascular outcomes. Am...

Descripción completa

Detalles Bibliográficos
Autores principales: Khedagi, Apurva, Hoke, Cara, Kelsey, Michelle, Coviello, Andrea, Jones, W. Schuyler, Jackson, Larry R., Patel, Manesh R, McGarrah, Rob W., Pagidipati, Neha J, Shah, Nishant P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
State-of-the-Art Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006446/
https://www.ncbi.nlm.nih.gov/pubmed/36915710
http://dx.doi.org/10.1016/j.ajpc.2023.100477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006446/
https://www.ncbi.nlm.nih.gov/pubmed/36915710
http://dx.doi.org/10.1016/j.ajpc.2023.100477

Ejemplares similares